NCT05722145View on ClinicalTrials.gov

Global Pretest Probability Study of Coronary Artery Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

200,000

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Coronary Artery Disease
Trial Locations (1)

169609

National Heart Centre Singapore, Singapore

All Listed Sponsors
lead

National Heart Centre Singapore

OTHER

NCT05722145 - Global Pretest Probability Study of Coronary Artery Disease | Biotech Hunter | Biotech Hunter